期刊文献+

SUM04基因多态性与冠心病及2型糖尿病合并冠心病的关系

Association between SUM04 polymorphisms and coronary artery disease with and without type 2 diabetes mellitus
原文传递
导出
摘要 目的探讨北京地区汉族人群小泛素样修饰蛋白4(small ubiquitin-like modifier4,SUM04)基因多态性与冠状动脉粥样硬化性心脏病(coronary artery disease,CAD)及2型糖尿病(type2 diabetes mellitus,T2DM)合并CAD的关系。方法采用病例对照设计,人选369例单纯CAD患者(CAD组)、189例2型糖尿病合并CAD患者(T2DM-4-CAD组)及500名健康个体(对照组)。应用聚合酶链反应一高分辨熔解曲线技术结合测序验证法,检测SUM04基因rs237025、rs237024及rs6007393个单核苷酸多态性(single nucleotide polymorphisms,SNPs)位点的基因型与等位基因在3组间的分布,并通过分层分析比较SNPs不同基因型携带者的临床相关危险因素的差异。结果3个SNPs的等位基因和基因型在3组间的分布差异无统计学意义(P〉0.05);通过分层分析,在T2DM4-CAD组发现rs237025各基因型携带者的甘油三酯水平、rs600739各基因型携带者的体重指数水平的差异有统计学意义(P值分别为0.020和0.049),但组间多重比较仅发现rs237025的GG基因型携带者较GA及AA基因型携带者具有更高的甘油三酯水平(P〈0.01)。结论SUMO4基因多态性可能与北京地区汉族人群伴或不伴T2DM的CAD易感性无关。 Objective To assess the role of small ubiquitin-like modifier 4 (SUM04)gene polymorphisms (rs237025,rs237024 and rs600739) in the susceptibility to coronary artery disease (CAD) with and without type 2 diabetes mellitus (T2DM) in Chinese Han ethnic population in Beijing. Methods In this case-control study, 558 subjects with angiography-proven CAD were divided into two groups according to the WHO 1999 criteria: 369 with normal glucose tolerance (CAD group) and 189 with T2DM (T2DM+CAD group). Meanwhile 500 healthy subjects free of T2DM and CAD were selected as normal controls (control group). Allelic and genotypic distributions of the three single nucleotide polymorphisms (SNPs) were determined with polymerase chain reaction-high resolution melting curve (PCR-HRM) and gene sequencing. Clinical and biochemical data were compared among carriers of different genotypes through a stratified analysis. Results No significant difference was found in the distribution of genotypes and alleles of each SNP between different groups (P〈0.05). Nevertheless, stratified analysis indicated a significant difference in plasma triglycerides (rs237025) and body mass index (rs600739) among individuals of different genotypes from the T2DM+CAD group (P=0. 020 and P=0. 049, respectively). Multiple comparison also indicated that GG genotype of rs237025 had a higher level of plasma triglycerides than AA genotype (P〈 0.01), Conclusion No association between SUM04 gene polymorphisms and CAD with and without T2DM was detected. Such polymorphisms may not be a risk factor for Chinese Han ethnic patients in Beijing.
出处 《中华医学遗传学杂志》 CAS CSCD 北大核心 2012年第5期596-601,共6页 Chinese Journal of Medical Genetics
关键词 SUMO4基因 多态性 冠状动脉粥样硬化性心脏病 2型糖尿病合并冠状动脉粥样硬化性心脏病 SUM04 gene Polymorphisms Coronary artery disease Type 2 diabetes mellitus with coronary artery disease
  • 相关文献

参考文献5

二级参考文献61

  • 1龚艳君,霍勇.64排CT冠状动脉成像的临床应用现况[J].中国介入心脏病学杂志,2005,13(6):416-416. 被引量:26
  • 2Bainey KR,Norris CM,Graham MM,et al.Clinical in-stent restenoeis with bare metal stents:is it truly a benign phenomenon?Int J Cardiol,2008,128:378-382.
  • 3Suselbeck T,Latsch A,Siri H,et al.Role of vessel size as a predictor for the occurrence of in-stent restenosis in patients with diabetes meilitus.Am J Cardiol,2001,88:243-247.
  • 4Iijima R,Ndrepepa G,Mehilli J,et al.Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era.Am Heart J,2007,154:688-693.
  • 5Nishio K,Sakurai M,Knsuyama T,et al.A randomized comparison of pioglitazone to inhibit restenosis after coronary stenting in patients with type 2 diabetes.Diabetes Care,2006,29:101-106.
  • 6Mehran R,Dangas GD,Kobayashi Y,et al.Short-and long-term results after multivessel stenting in diabetic patients.J Am Coil Cardiol,2004,43:1348-1354.
  • 7Moustapha A,Assali AR,Sdringola S,et al.Percutancous and surgical interventions for in-stent restenosis:long-term outcomes and effect of diabetes mellitus.J Am Coil Cardiol,2001,37:1877-1882.
  • 8Cole JH,Jones EL,Craver JM,et al.Outcomes of repeat revascularization in diabetic patients with prior coronary surgery.J Am Coll Cardiol,2002,40:1968-1975.
  • 9Yang WS,Jeng CY,Wu T J, et al. Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients. Diabetes Care, 2002,25 : 376-380.
  • 10Ouchi N,Kihara S,Arita Y, et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation, 2001,103 : 1057-1063.

共引文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部